New Era for Cervical Cancer Screening: Self-Swab HPV Tests Approved


The American Cancer Society (ACS) has updated its cervical cancer screening guidelines to include self-administered Human Papillomavirus (HPV) tests, a change experts hope will increase screening rates.

Key Changes and Rationale

  • Self-Swab Option: The updated guidelines introduce "self-swab" HPV tests, providing an alternative to the traditional speculum exam and pelvic discomfort often associated with Pap tests (cytology).
  • Focus on HPV: Testing for HPV—the virus that causes nearly all cervical cancers—has replaced the Pap test as the preferred method for primary screening. As Jane Montealegre of the University of Texas MD Anderson Cancer Center noted, "HPV is such a strong indicator of cervical cancer; we know now that screening for HPV is screening for cervical cancer."
  • Improving Access: Despite steadily falling cervical cancer rates since the 1970s (largely due to screening and the HPV vaccine), over 20% of American women remain unscreened. The self-administered tests, three of which have been FDA-approved since 2024 (including one for at-home use), allow patients to collect their own vaginal swab sample.

Robert Smith, Senior VP of early cancer detection science for the ACS, described the process: “A woman would be given a kit and could go some place, either the exam room or bathroom, and collect her own sample.”

Screening Recommendations: ACS vs. USPSTF

Both the ACS and the U.S. Preventive Services Task Force (USPSTF) recommend HPV testing as the primary screening method and the "gold standard" for cervical cancer.

RecommendationACS Updated GuidelinesUSPSTF Current Recommendation
Primary TestHPV TestHPV Test
Interval (HPV)Every 5 yearsEvery 5 years (Starting at 30)
Screening StartAge 25Age 30 (Ages 21-29 screen with cytology every 3 years)
AlternativePap Test every 3 years, or both every 5 yearsPap Test every 3 years, or both every 5 years

The USPSTF is expected to update its guidelines soon to include self-administered tests, which are likely to be covered by insurance under the Affordable Care Act.

New Guidance on Stopping Screening

The new ACS guidelines also clarify when a woman can stop screening, recommending cessation at age 65 only if a woman has had consistent screening with negative results for at least a decade.

Dr. Diane Harper, a professor of obstetrics and gynecology at the University of Michigan, expects that as the vaccinated population grows, screening intervals may lengthen even further, potentially to every 10 years in the future.


Disclaimer: This content is published only for health awareness and informational purposes. It's not a substitute for your professional medical advice. You must consult a doctor/healthcare professional regarding your specific health concerns.

Post a Comment

0 Comments